Doctor laughing with young girl

Guidelines for the
treatment of ADHD

Long acting Xenidate XL meets NICE treatment guidance for ADHD

NICE guideline 87:9

  • “Offer methylphenidate (either short or long acting) as the first line pharmacological treatment for children aged 5 years and over and young people with ADHD”


Xenidate XL meets the Medicines Value Programme criteria

The Medicines Value Programme has been set up to improve health outcomes from medicines and too ensure the best value is achieved.10

Medicines Value Programme aims include:

  • “Enable people to access treatment that is clinically effective, based on the latest scientific discovery, at as low a price as possible
  • Xenidate XL is a high quality generic of Concerta XL, with demonstrated bioequivalence, a similar biphasic release profile and costs the NHS 50% less.1-3

Click below for more information about the Medicines Value Programme